Twelve Points Wealth Management’s Bicycle Therapeutics BCYC Stock Holding History

Twelve Points Wealth Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,200	Closed	-$213K	–	164
2022 Q4	$213K	Buy	+7,200	New	+$193K	0.15%	150
2022 Q2	–	Sell	-7,100	Closed	-$312K	–	164
2022 Q1	$312K	Hold	7,100	–	–	0.23%	137
2021 Q4	$432K	Buy	+7,100	New	+$392K	0.35%	104

Other funds holding BCYC

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Twelve Points Wealth Management's BCYC Position: Q1 2023 in Review

Twelve Points Wealth Management sold out of Bicycle Therapeutics (BCYC) in Q1 2023, closing a stake of 7,200 shares — an estimated $213K sold.

Twelve Points Wealth Management first reported a position in BCYC in Q4 2021 and held it in 3 quarters. The position peaked at $432K in Q4 2021. 89 funds tracked by Wall St. Rank hold BCYC as of Q1 2023.

Twelve Points Wealth Management reported no remaining Bicycle Therapeutics position as of Q1 2023 after selling out during the quarter.
Twelve Points Wealth Management sold 7,200 Bicycle Therapeutics shares in Q1 2023, an estimated $213K.
Twelve Points Wealth Management first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 3 quarters.
Twelve Points Wealth Management's Bicycle Therapeutics position peaked at $432K in Q4 2021.
89 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2023.

Based on Twelve Points Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.